HomeAVTX • NASDAQ
add
Avalo Therapeutics Inc
Previous close
$4.90
Day range
$4.69 - $5.09
Year range
$4.44 - $17.49
Market cap
51.33M USD
Avg Volume
97.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 192.00K | -66.37% |
Operating expense | 7.96M | 104.34% |
Net income | -35.34M | -332.65% |
Net profit margin | -18.41K | -1,186.69% |
Earnings per share | -2.74 | — |
EBITDA | -13.24M | -257.15% |
Effective tax rate | -0.32% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 134.55M | 1,714.51% |
Total assets | 150.73M | 618.01% |
Total liabilities | 17.70M | 29.30% |
Total equity | 133.03M | — |
Shares outstanding | 10.67M | — |
Price to book | 0.39 | — |
Return on assets | -26.71% | — |
Return on capital | -42.04% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -35.34M | -332.65% |
Cash from operations | -15.04M | -443.89% |
Cash from investing | 0.00 | — |
Cash from financing | 67.71M | 6,770,800.00% |
Net change in cash | 52.66M | 2,004.70% |
Free cash flow | -66.13M | -1,302.80% |
About
Founded
2011
Headquarters
Website
Employees
23
